Hedyotis diffusa willd inhibits colorectal cancer growth in vivo via inhibition of STAT3 signaling pathway

International Journal of Molecular Sciences

Volumn 13, Issue 5, 2012, Pages 6117-6128

  Cai, Qiaoyan ^a   Lin, Jiumao ^a   Wei, Lihui ^a   Zhang, Ling ^a   Wang, Lili ^a   Zhan, Youzhi ^a   Zeng, Jianwei ^a   Xu, Wei ^a   Shen, Aling ^a   Hong, Zhenfeng ^a   Peng, Jun ^a  

^a FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Apoptosis; Chinese medicine; Colorectal cancer; Hedyotis diffusa willd; Proliferation; STAT3 pathway

Indexed keywords

ALCOHOL; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; HEDYOTIS DIFFUSA EXTRACT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; SODIUM CHLORIDE; STAT3 PROTEIN; ANTINEOPLASTIC AGENT; PLANT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE MODEL; DRUG CYTOTOXICITY; HEDYOTIS; HEDYOTIS DIFFUSA; HUMAN; HUMAN CELL; IN VIVO STUDY; INHIBITION KINETICS; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR VOLUME; UPREGULATION; WEIGHT GAIN; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; COLORECTAL NEOPLASMS; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; HT 29 CELL LINE; MEDICINAL PLANT; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

HEDYOTIS DIFFUSA; MUS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEDYOTIS; HT29 CELLS; HUMANS; MICE; MICE, INBRED BALB C; PHOSPHORYLATION; PLANT EXTRACTS; PLANTS, MEDICINAL; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84861553415     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13056117     Document Type: Article

References (38)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M.J. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58, 71-96.
2. Renehan, A.G.; Egger, M.; Saunders, M.P.; O'Dwyer, S.T. Impact on survival of intensive follow up after curative resection for colorectal cancer: Systematic review and meta-analysis of randomised trials. BMJ 2002, 324, doi:10.1136/bmj.324.7341.813.
3. Prat, A.; Casado, E.; Cortés, J. New approaches in angiogenic targeting for colorectal cancer. World J. Gastroenterol. 2007, 13, 5857-5866.
4. Sun, Y.; Zhao, H.; Guo, Y.; Lin, F.; Tang, L.; Yao, Y. Clinical study of combining chemotherapy of oxaliplatin or 5-fluorouracil/leucovorin with hydroxycamptothecine for advanced colorectal cancer. Clin. Oncol. Cancer Res. 2009, 6, 117-123.
5. Zhao, J.; Jiang, P.; Zhang, W. Molecular networks for the study of TCM Pharmacology. Brief. Bioinform. 2010, 11, 417-430.
6. Bromberg, J.; Darnell, J.E., Jr. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000, 19, 2468-2473.
7. Levy, D.E.; Lee, C. What does Stat3 do? J. Clin. Invest. 2002, 109, 1143-1148.
8. Ernst, M.; Jenkins, B.J. Acquiring signalling specificity from the cytokine receptor gp130. Trends Genet. 2004, 20, 23-32.
9. Kamimura, D.; Ishihara, K.; Hirano, T. IL-6 signal transduction and its physiological roles: The signal orchestration model. Rev. Physiol. Biochem. Pharmacol. 2003, 149, 1-38.
10. Darnell, J.E., Jr. STATs and gene regulation. Science 1997, 277, 1630-1635.
11. Masuda, M.; Suzui, M.; Yasumatu, R.; Nakashima, T.; Kuratomi, Y.; Azuma, K.; Tomita, K.; Komiyama, S.; Weinstein, I.B. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res. 2002, 62, 3351-3355.
12. Bromberg, J.; Wang, T.C. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 2009, 15, 79-80.
13. Darnell, J.E. Transcription factors as targets for cancer therapy. Nat. Rev. Cancer 2002, 2, 740-749.
14. Lin, Q.; Lai, R.; Chirieac, L.R.; Li, C.; Thomazy, V.A.; Grammatikakis, I.; Rassidakis, G.Z.; Zhang, W.; Fujio, Y.; Kunisada, K. Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: Inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells. Am. J. Pathol. 2005, 167, 969-980.
15. Xiong, H.; Zhang, Z.G.; Tian, X.Q.; Sun, D.F.; Liang, Q.C.; Zhang, Y.J.; Lu, R.; Chen, Y.X.; Fang, J.Y. Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia 2008, 10, 287-297.
16. Ahmad, R.; Ali, A.M.; Israf, D.A.; Ismail, N.H.; Shaari, K.; Lajis, N.H. Antioxidant, radical-scavenging, anti-inflammatory, cytotoxic and antibacterial activities of methanolic extracts of some Hedyotis species. Life Sci. 2005, 76, 1953-1964.
17. Lin, C.C.; Ng, L.T.; Yang, J.J.; Hsu, Y.F. Anti-inflammatory and hepatoprotective activity of peh-hue-juwa-chi-cao in male rats. Am. J. Chin. Med. 2002, 30, 225-234.
18. Ren, F.; Liu, G.; Zhang, L.; Niu, G. Studies on chemical constituents of Hedyotis diffusa Willd. Chin. Pharm. J. 2005, 40, 502-504.
19. Ahmad, R.; Shaari, K.; Lajis, N.H.; Hamzah, A.S.; Ismail, N.H.; Kitajima, M. Anthraquinones from Hedyotis capitellata. Phytochemistry 2005, 66, 1141-1147.
20. Li, C.; Xue, X.; Zhou, D.; Zhang, F.; Xu, Q.; Ren, L.; Liang, X. Analysis of iridoid glucosides in Hedyotis diffusa by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. J. Pharm. Biomed. Anal. 2008, 48, 205-211.
21. Lin, J.; Chen, Y.; Wei, L.; Chen, X.; Xu, W.; Hong, Z.; Sferra, T.J.; Peng, J. Hedyotis diffusa Willd extract induces apoptosis via activation of the mitochondrion-dependent pathway in human colon carcinoma cells. Int. J. Oncol. 2010, 37, 1331-1338.
22. Lin, J.; Wei, L.; Xu, W.; Hong, Z.; Liu, X.; Peng, J. Effect of Hedyotis diffusa Willd extract on tumor angiogenesis. Mol. Med. Rep. 2011, 4, 1283-1288.
23. Zhu, X.H.; Li, S.J.; Hu, H.H.; Sun, L.R.; Das, M.; Gao, T.M. Neuroprotective effects of Xiao-Xu-Ming decoction against ischemic neuronal injury in vivo and in vitro. J. Ethnopharmacol. 2010, 127, 38-46.
24. Longley, D.B.; Allen, W.L.; Johnston, P.G. Drug resistance, predictive markers and pharmacogenomics in colorectal cancer. Biochim. Biophys. Acta 2006, 1766, 184-196.
25. Gordaliza, M. Natural products as leads to anticancer drugs. Clin. Transl. Oncol. 2007, 9, 767-776.
26. Song, L.R. Zhong Hua Ben Cao; Shanghai Science and Technology Press: Shanghai, China, 1999; p. 433.
27. Liu, B.; Yao Z. Clinical study of Hedyotis diffusa Willd injection in treating primary liver cancer (in Chinese). J. Med. Forum 2004, 25, 37-39.
28. Lu, B.; Lin, N.; He, X.; Zhou, X. Analysis on the clinical application of Hedyotis diffusa Willd in the anti-cancer therapy. Chin. J. Chin. Mater. Med. 2006, 31, 1550-1552.
29. Adams, J.; Cory, S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007, 26, 1324-1337.
30. Youle, R.J.; Strasser, A. The BCL-2 protein family: Opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9, 47-59.
31. Nurse, P. Ordering S phase and M phase in the cell cycle. Cell 1994, 79, 547-550.
32. Morgan, D.O. Principles of CDK regulation. Nature 1995, 374, 131-134.
33. Harakeh, S.; Abu-El-Ardat, K.; Diab-Assaf, M.; Niedzwiecki, A.; El-Sabban, M.; Rath, M. Epigallocatechin-3-gallate induces apoptosis and cell cycle arrest in HTLV-1-positive and -negative leukemia cells. Med. Oncol. 2008, 25, 30-39.
34. Kessel, D.; Luo, Y. Cells in cryptophycin-induced cell-cycle arrest are susceptible to apoptosis. Cancer Lett. 2000, 151, 25-29.
35. Purohit, A.; Hejaz, H.A.M.; Walden, L.; MacCarthy-Morrogh, L.; Packham, G.; Potter, B.V.L.; Reed, M.J. The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours. Int. J. Cancer 2000, 85, 584-589.
36. Zafonte, B.T.; Hulit, J.; Amanatullah, D.F.; Albanese, C.; Wang, C.; Rosen, E.; Reutens, A.; Sparano, J.A.; Lisanti, M.P.; Pestell, R.G. Cell-cycle dysregulation in breast cancer: Breast cancer therapies targeting the cell cycle. Front. Biosci. 2000, 5, D938-D961.
37. Domagala, W.; Welcker, M.; Chosia, M.; Karbowniczek, M.; Harezga, B.; Bartkova, J.; Bartek, J.; Osborn, M. p21/WAF1/Cip1 expression in invasive ductal breast carcinoma: Relationship to p53, proliferation rate, and survival at 5 years. Virchows Arch. 2001, 439, 132-140.
38. Zushi, S.; Shinomura, Y.; Kiyohara, T.; Miyazaki, Y.; Kondo, S.; Sugimachi, M.; Higashimoto, Y.; Kanayama, S.; Matsuzawa, Y. STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells. Int. J. Cancer 1998, 78, 326-330.